54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 05
15:28 UTC
|
LSCC
Lattice Semiconductor
|
◎ Target | John Vinh ★★☆☆☆ #2532 | Overweight | $165.00→ $180.00+9.1% |
|
Aug 05
15:28 UTC
|
LMAT
LeMaitre Vascular
|
◎ Target | Nathan Treybeck ★★★☆☆ #1247 | Equal Weight | $104.00→ $94.00-9.6% |
|
Aug 05
15:28 UTC
|
LIME
Neutron
|
◎ Target | Justin Patterson ★★★☆☆ #1685 | Overweight | $33.00→ $37.00+12.1% |
|
Aug 05
15:28 UTC
|
IT
Gartner
|
◎ Target | Jason Haas not yet tracked | Underweight | $120.00→ $150.00+25.0% |
|
Aug 05
15:28 UTC
|
HNGE
Hinge Health
|
◎ Target | Stan Berenshteyn ★★★★★ #317 | Overweight | $90.00→ $103.00+14.4% |
|
Aug 05
15:28 UTC
|
HNGE
Hinge Health
|
◎ Target | Aaron Kimson ★★★★☆ #918 | Market Outperform | $96.00→ $107.00+11.5% |
|
Aug 05
15:28 UTC
|
GPK
Graphic Packaging
|
◎ Target | Gabe Hajde not yet tracked | Underweight | $9.00→ $10.00+11.1% |
|
Aug 05
15:28 UTC
|
FANG
Diamondback Energy
|
◎ Target | Sam Margolin ★★★★☆ #754 | Overweight | $262.00→ $263.00+0.4% |
|
Aug 05
15:28 UTC
|
CTRI
Centuri
|
◎ Target | Zachary Schechtman not yet tracked | Overweight | $37.00→ $29.00-21.6% |
|
Aug 05
15:28 UTC
|
CSWC
Capital Southwest
|
◎ Target | Chris Muller ★★★☆☆ #1921 | Market Outperform | $25.00→ $26.00+4.0% |
|
Aug 05
15:28 UTC
|
COMP
Compass
|
◎ Target | Alec Brondolo ★★★☆☆ #1228 | Equal Weight | $12.00→ $13.00+8.3% |
|
Aug 05
15:28 UTC
|
CMTG
Claros Mortgage Trust
|
◎ Target | Donald Fandetti ★★★☆☆ #1804 | Underweight | $2.50→ $1.75-30.0% |
|
Aug 05
15:28 UTC
|
CALY
Topgolf Callaway Brands
|
◎ Target | Noah Zatzkin ★★☆☆☆ #2495 | Overweight | $19.00→ $22.00+15.8% |
|
Aug 05
15:28 UTC
|
BP
BP
|
◎ Target | Sam Margolin ★★★★☆ #754 | Equal Weight | $54.00→ $48.00-11.1% |
|
Aug 05
15:28 UTC
|
BIO
Bio-Rad Laboratories
|
◎ Target | Evan Stampler not yet tracked | Equal Weight | $310.00→ $330.00+6.5% |
|
Aug 05
15:28 UTC
|
BALL
Ball
|
◎ Target | Gabe Hajde not yet tracked | Overweight | $71.00→ $72.00+1.4% |
|
Aug 05
15:28 UTC
|
APTV
Aptiv
|
◎ Target | Colin Langan ★★☆☆☆ #2484 | Overweight | $77.00→ $66.00-14.3% |
|
Aug 05
15:28 UTC
|
AOMR
Angel Oak Mortgage REIT
|
◎ Target | Donald Fandetti ★★★☆☆ #1804 | Overweight | $11.00→ $10.00-9.1% |
|
Aug 05
15:28 UTC
|
AMGN
Amgen
|
◎ Target | Mohit Bansal ★★★☆☆ #1220 | Equal Weight | $390.00→ $400.00+2.6% |
|
Aug 05
15:28 UTC
|
AME
AMETEK
|
◎ Target | Steve Barger ★★☆☆☆ #2506 | Overweight | $260.00→ $295.00+13.5% |
|
Aug 05
15:28 UTC
|
ACEL
Accel Entertainment
|
◎ Target | Jordan Bender ★★☆☆☆ #2884 | Market Outperform | $14.00→ $15.00+7.1% |
|
Aug 05
15:28 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | Jason N. Butler not yet tracked | Market Outperform | $35.00→ $36.00+2.9% |
|
Aug 05
15:28 UTC
|
TMQ
Trilogy Metals
|
↓ Downgrade | firm only | Hold | |
|
Aug 05
15:28 UTC
|
ROL
Rollins
|
↓ Downgrade | John Eade ★★★★☆ #865 | Buy→ Hold | |
|
Aug 05
15:28 UTC
|
ILMN
Illumina
|
↓ Downgrade | firm only | Hold | |
|
Aug 05
15:28 UTC
|
BMY
Bristol Myers Squibb
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Aug 05
15:28 UTC
|
BMY
Bristol Myers Squibb
|
↓ Downgrade | firm only | Buy→ Hold | |
|
Aug 05
15:28 UTC
|
AMAT
Applied Materials
|
↓ Downgrade | firm only | Buy→ Hold | |
|
Aug 05
15:28 UTC
|
VGNT
Versigent
|
↑ Upgrade | Tom Narayan ★★★☆☆ #1672 | Sec→ r Perform ➝ Outperform | $41.00→ $52.00+26.8% |
|
Aug 05
15:28 UTC
|
DLR
Digital Realty Trust
|
↑ Upgrade | Eric Luebchow ★★☆☆☆ #2766 | Overweight→ Buy | |
|
Aug 05
15:28 UTC
|
CRM
Salesforce
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Aug 05
15:28 UTC
|
BMY
Bristol Myers Squibb
|
↑ Upgrade | firm only | Market Perform→ Outperform | |
|
Aug 05
15:28 UTC
|
ABBV
AbbVie
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Aug 05
14:28 UTC
|
ZBRA
Zebra Technologies
|
◎ Target | Guy Hardwick ★★★★☆ #876 | Overweight | $346.00→ $410.00+18.5% |
|
Aug 05
14:28 UTC
|
WYNN
Wynn Resorts
|
◎ Target | Brandt Montour ★★★☆☆ #1506 | Overweight | $134.00→ $136.00+1.5% |
|
Aug 05
14:28 UTC
|
WYNN
Wynn Resorts
|
◎ Target | Trey Bowers ★★★☆☆ #1439 | Overweight | $141.00→ $131.00-7.1% |
|
Aug 05
14:28 UTC
|
WAT
Waters
|
◎ Target | Luke Sergott ★★★★★ #69 | Overweight | $425.00→ $460.00+8.2% |
|
Aug 05
14:28 UTC
|
W
Wayfair
|
◎ Target | Zachary Fadem ★★★★☆ #960 | Overweight | $100.00→ $130.00+30.0% |
|
Aug 05
14:28 UTC
|
W
Wayfair
|
◎ Target | Ygal Arounian ★★★☆☆ #2067 | Neutral | $85.00→ $125.00+47.1% |
|
Aug 05
14:28 UTC
|
VRTX
Vertex Pharmaceuticals
|
◎ Target | Eliana Merle ★★★☆☆ #1386 | Overweight | $615.00→ $617.00+0.3% |
|
Aug 05
14:28 UTC
|
VIK
Viking
|
◎ Target | Trey Bowers ★★★☆☆ #1439 | Overweight | $109.00→ $128.00+17.4% |
|
Aug 05
14:28 UTC
|
TPG
TPG
|
◎ Target | Benjamin Budish ★★★★☆ #729 | Overweight | $58.00→ $64.00+10.3% |
|
Aug 05
14:28 UTC
|
TOST
Toast
|
◎ Target | Nik Cremo ★★★☆☆ #1517 | Overweight | $35.00→ $39.00+11.4% |
|
Aug 05
14:28 UTC
|
TKO
TKO Group
|
◎ Target | Curry Baker ★★★☆☆ #1886 | Buy | $230.00→ $235.00+2.2% |
|
Aug 05
14:28 UTC
|
TDC
Teradata
|
◎ Target | Raimo Lenschow ★★★★☆ #661 | Underweight | $28.00→ $27.00-3.6% |
|
Aug 05
14:28 UTC
|
SYRE
Spyre Therapeutics
|
◎ Target | Yatin Suneja ★☆☆☆☆ #2948 | Buy | $115.00→ $130.00+13.0% |
|
Aug 05
14:28 UTC
|
SYRE
Spyre Therapeutics
|
◎ Target | David Nierengarten ★★☆☆☆ #2467 | Outperform | $100.00→ $130.00+30.0% |
|
Aug 05
14:28 UTC
|
SUNC
SunocoCorp
|
◎ Target | Theresa Chen ★★★☆☆ #1737 | Overweight | $78.00→ $80.00+2.6% |
|
Aug 05
14:28 UTC
|
SUN
Sunoco
|
◎ Target | Ned Baramov ★★☆☆☆ #2418 | Overweight | $77.00→ $82.00+6.5% |
|
Aug 05
14:28 UTC
|
SUN
Sunoco
|
◎ Target | Theresa Chen ★★★☆☆ #1737 | Overweight | $78.00→ $80.00+2.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.